Corient Capital Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$1.56M Buy
25,218
+1,705
+7% +$105K 0.12% 156
2022
Q2
$1.45M Buy
23,513
+4,917
+26% +$304K 0.11% 168
2022
Q1
$1.11M Sell
18,596
-1,003
-5% -$59.7K 0.07% 230
2021
Q4
$1.42M Buy
19,599
+465
+2% +$33.8K 0.09% 190
2021
Q3
$1.34M Buy
19,134
+129
+0.7% +$9.01K 0.1% 193
2021
Q2
$1.31M Buy
19,005
+1,761
+10% +$121K 0.1% 189
2021
Q1
$1.12M Buy
17,244
+5,865
+52% +$379K 0.1% 188
2020
Q4
$663K Sell
11,379
-4,064
-26% -$237K 0.07% 231
2020
Q3
$976K Sell
15,443
-4,921
-24% -$311K 0.11% 168
2020
Q2
$1.57M Buy
20,364
+5,869
+40% +$452K 0.19% 110
2020
Q1
$1.08M Buy
14,495
+3,132
+28% +$234K 0.17% 117
2019
Q4
$739K Buy
11,363
+839
+8% +$54.6K 0.09% 222
2019
Q3
$667K Sell
10,524
-405
-4% -$25.7K 0.09% 218
2019
Q2
$738K Buy
10,929
+3,683
+51% +$249K 0.11% 187
2019
Q1
$471K Sell
7,246
-22,726
-76% -$1.48M 0.08% 230
2018
Q4
$1.88M Sell
29,972
-12,054
-29% -$754K 0.33% 86
2018
Q3
$3.25M Hold
42,026
0.54% 43
2018
Q2
$2.98M Buy
42,026
+5,877
+16% +$416K 0.52% 45
2018
Q1
$2.73M Buy
36,149
+16,708
+86% +$1.26M 0.5% 51
2017
Q4
$1.39M Sell
19,441
-14,421
-43% -$1.03M 0.24% 103
2017
Q3
$2.74M Sell
33,862
-10,064
-23% -$816K 0.52% 47
2017
Q2
$3.11M Sell
43,926
-645
-1% -$45.7K 0.48% 53
2017
Q1
$3.03M Sell
44,571
-661
-1% -$44.9K 0.47% 47
2016
Q4
$3.24M Buy
45,232
+15,005
+50% +$1.07M 0.57% 39
2016
Q3
$2.39M Buy
+30,227
New +$2.39M 0.44% 49